9 results
P
Von Hippel-Lindau (VHL) disease patients with central nervous system benign hemangioblastomas (CHB)
I/C
Stereotactic radiosurgery (SRS), Various radiosurgery methods, marginal doses, maximum doses, the number of tumors for radiosurgery, age at the time of radiosurgery, tumor locations
O
5-year tumor control rates (TCR)
P
severe COVID-19 patients, non-severe COVID-19 patients, healthy controls
I/C
KL-6 measurement, severe vs. non-severe COVID-19 patients, severe COVID-19 patients vs. healthy controls
O
serum KL-6 levels
P
children, adults
I/C
playing a wind instrument, controls
O
tooth position, facial morphology
P
human adipose tissue
I/C
DNA microarray datasets, type 2 diabetes (T2D) and metabolic syndrome (MetS)
O
key metagenes
P
ACS, ECG, AI
I/C
AI-based detection, case-control studies
O
accurate diagnosis and prompt treatment
P
ARDS/ALI patients
I/C
pulmonary-originated epithelial proteins, traditional diagnostic criteria
O
distinguishing at-risk patients, predicting mortality
P
ILD patients
I/C
Elevated KL-6 levels, Severe and progressive ILD groups, Non-progressive ILD group, Stable ILD, Survivors of ILD
O
Poor outcomes, Mortality, Progression of ILD
P
oral squamous cell carcinoma (OSCC) patients
I/C
machine learning models for diagnostic or prognostic purposes
O
diagnostic and prognostic accuracy